R2032923 |
RAF709 |
RAF709 is a potent, selective, and efficacious RAF inhibitor with IC50s of 0.4 n
|
R2032924 |
RO6885247 |
RG7800 is a SMN2 splicing modifier.RG7800 has the potential for spinal muscular
|
R2032925 |
SUN11602 |
SUN11602 is a novel aniline compound with basic fibroblast growth factor-like ac
|
R2032926 |
UNC3866 |
UNC3866 is a potent antagonist of the CBX7-H3 interaction as determined by Alpha
|
R2032927 |
BMS309403 |
BMS-309403 is a potent, selective and cell-permeable inhibitor of adipocyte fatt
|
R2032928 |
CCT251236 |
CCT251236 is an orally available pirin ligand from a heat shock transcription fa
|
R2032929 |
CPI-268456 |
CPI-268456 is a potential BET bromodomain inhibitor.
|
R2032930 |
BRD-6125 |
FPH1 (BRD-6125) is a small molecule, which promotes expansion of iPS-derived hep
|
R2032931 |
Glesatinib hydrochloride |
Glesatinib hydrochloride is an inhibitor of the MET and Axl receptor tyrosine ki
|
R2032932 |
Ziritaxestat(GLPG1690) |
Ziritaxestat (GLPG1690) is a first-in-class autotaxin (ATX) inhibitor, with an I
|
R2032933 |
IRAK inhibitor 6 |
IRAK inhibitor 6 is an inhibitor of interleukin-1 receptor associated kinase 4 (
|
R2032934 |
SB649868;GSK649868 |
SB-649868 is a potent and selective orally active orexin (OX) 1 and OX2 receptor
|
R2032935 |
Vadadustat |
Vadadustat is a novel, titratable, oral hypoxia-inducible factor prolyl hydroxyl
|
R2032936 |
Valbenazine |
Valbenazine is a prodrug of the (+)-α isomer of Ro 1-9569 for tardive syndrome t
|
R2032937 |
VH298 |
VH-298 is a highly potent inhibitor of the VHL:HIF-α interaction with a Kd value
|
R2032938 |
AG881 |
Vorasidenib (AG-881) is an orally available, brain penetrant second-generation d
|
R2032939 |
AX-024 hcl |
AX-024 is an orally available, first-in-class inhibitor of the TCR-Nck interacti
|
R2032940 |
AZD3839 |
AZD3839 (free base) is a potent and selective BACE1 inhibitor with IC50 of 23.6
|
R2032941 |
CFI-402257 |
CFI-402257 is a highly potent and selective TTK (threonine tyrosine kinase) Inhi
|
R2032942 |
Cobicistat |
Cobicistat is a potent and selective inhibitor of cytochrome P450 3A (CYP3A) enz
|
R2032943 |
Exatecan Mesylate |
Exatecan Mesylate is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.
|
R2032944 |
Glecaprevir;ABT-493 |
Glecaprevir is a novel HCV NS3/4A protease inhibitor, with IC50 values ranging f
|
R2032945 |
GNE140 |
(R)-GNE-140 is a potent lactate dehydrogenase A (LDHA) inhibitor, with IC50s of
|
R2032946 |
GSK2330672;Linerixibat |
Linerixibat (GSK2330672) is a highly potent, nonabsorbable and orally active api
|
R2032947 |
GSK5182 |
GSK5182 is a highly selective inverse agonist of estrogen-related receptor γ (ER
|